4
Changes in Ownership
Lyell Immunopharma, Inc. Filed Acc 0001415889-25-016729
Options or other derivatives
- General Counsel acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Meltz Mark A · General Counsel
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-09 | Grant or award : show line 1 in the form Option (right to buy) | +100,000 | 100,000 | D |
Loading xslF345X05/form4-06112025_090608.xml…